Pegasus Partners Ltd. bought a new position in The Allstate Co. (NYSE:ALL – Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 1,079 shares of the insurance provider’s stock, valued at approximately $205,000.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. Northwest Investment Counselors LLC purchased a new stake in Allstate in the 3rd quarter worth $28,000. Catalyst Capital Advisors LLC purchased a new stake in shares of Allstate in the third quarter worth about $29,000. Versant Capital Management Inc boosted its stake in Allstate by 70.9% during the second quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider’s stock valued at $30,000 after buying an additional 78 shares during the last quarter. Family Firm Inc. bought a new position in Allstate during the second quarter valued at approximately $38,000. Finally, MCF Advisors LLC grew its holdings in Allstate by 33.9% during the 2nd quarter. MCF Advisors LLC now owns 332 shares of the insurance provider’s stock valued at $53,000 after buying an additional 84 shares in the last quarter. Institutional investors own 76.47% of the company’s stock.
Insider Buying and Selling at Allstate
In other news, EVP Elizabeth Brady sold 49,481 shares of the stock in a transaction on Friday, August 16th. The stock was sold at an average price of $179.09, for a total transaction of $8,861,552.29. Following the transaction, the executive vice president now owns 19,163 shares of the company’s stock, valued at approximately $3,431,901.67. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, EVP Elizabeth Brady sold 49,481 shares of the company’s stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $179.09, for a total value of $8,861,552.29. Following the completion of the sale, the executive vice president now owns 19,163 shares of the company’s stock, valued at approximately $3,431,901.67. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider John E. Dugenske sold 36,367 shares of Allstate stock in a transaction that occurred on Friday, September 20th. The shares were sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the transaction, the insider now directly owns 27,364 shares in the company, valued at approximately $5,236,922.32. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 192,530 shares of company stock valued at $34,967,665 in the last ninety days. Corporate insiders own 1.80% of the company’s stock.
Allstate Price Performance
Allstate (NYSE:ALL – Get Free Report) last issued its earnings results on Wednesday, October 30th. The insurance provider reported $3.91 EPS for the quarter, topping analysts’ consensus estimates of $2.20 by $1.71. The business had revenue of $16.63 billion for the quarter, compared to analyst estimates of $14.57 billion. Allstate had a net margin of 6.77% and a return on equity of 26.67%. The company’s quarterly revenue was up 14.7% compared to the same quarter last year. During the same period last year, the company posted $0.81 earnings per share. As a group, sell-side analysts predict that The Allstate Co. will post 15.23 earnings per share for the current year.
Wall Street Analysts Forecast Growth
A number of research analysts have recently commented on ALL shares. StockNews.com downgraded Allstate from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, August 21st. UBS Group increased their price objective on shares of Allstate from $216.00 to $225.00 and gave the company a “buy” rating in a research report on Monday, November 4th. The Goldman Sachs Group boosted their target price on shares of Allstate from $199.00 to $204.00 and gave the stock a “buy” rating in a report on Thursday, August 15th. BMO Capital Markets increased their price target on shares of Allstate from $205.00 to $214.00 and gave the company an “outperform” rating in a report on Friday, October 18th. Finally, Evercore ISI lifted their price target on Allstate from $191.00 to $195.00 and gave the stock an “in-line” rating in a research report on Wednesday, October 9th. One research analyst has rated the stock with a sell rating, two have given a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $212.56.
Allstate Company Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Read More
- Five stocks we like better than Allstate
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
- What is the FTSE 100 index?
- MarketBeat Week in Review – 11/4 – 11/8
- What is the S&P 500 and How It is Distinct from Other Indexes
- Trump’s Return: Which Sectors Will Benefit Most?
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.